Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2014-09-24 15:18:15
Reporting Period:
Filing Date:
Accepted Time:
2014-09-24 15:18:15
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1403708 Evoke Pharma Inc EVOK Pharmaceutical Preparations (2834) 208447886
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579179 C Todd Brady C/o Evoke Pharma, Inc.
505 Lomas Santa Fe Drive, Suite 270
Solana Beach CA 92075
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-23 4,000 $5.70 4,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $5.69 to $5.7507 per share, inclusive. The Reporting Person will provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.